Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG)

CAPS Rating: 2 out of 5

The Company is seeking to develop and commercialize new diagnostic and therapeutic products based on a recently discovered group of genes known as microRNAs.

Recs

0
Player Avatar pchop123 (79.55) Submitted: 11/23/2012 1:35:43 PM : Outperform Start Price: $4.82 ROSG Score: -6.40

Just do it !!!

Featured Broker Partners


Advertisement